Critical Care

official impact factor 4.60

Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?

Moritoki Egi, Rinaldo Bellomo* and Michael C Reade

Critical Care 2009, 13:302 doi:10.1186/cc7755

Accesses  

  • Last 30 days: 48 accesses
  • Last year: 655 accesses
  • All time: 2246 accesses

Cited by

BioMed Central: 3 citations

Review   Free

Clinical review: Strict or loose glycemic control in critically ill patients - implementing best available evidence from randomized controlled trials

Marcus J Schultz, Robin E Harmsen, Peter E Spronk Critical Care 2010, 14:223 (7 June 2010)

Poster presentation   Free

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients

R Brunner, R Kitzberger, W Miehsler, V Fuhrmann, C Madl, U Holzinger Critical Care 2010, 14(Suppl 1):P577 (1 March 2010)

Commentary   Free

NICE-SUGAR: the end of a sweet dream?

Jean-Charles Preiser Critical Care 2009, 13:143 (14 May 2009)